富含透明质酸转移液对冻胚移植活产率的影响:随机双盲对照试验
意向性分析显示两组活产率无差异(25.5% vs 25.8%;RR 0.99;95%CI 0.74-1.31),富含透明质酸转移液未提高冻胚移植活产率。
要点
- 富含透明质酸转移液组与标准液组活产率分别为25.5%和25.8%,差异无统计学意义。
- Logistic回归显示转移液类型与活产无关联。
- 两组其他临床结局也相似,未观察到富含透明质酸转移液的额外获益。
核心结论
- 与标准转移液相比,使用富含透明质酸的转移液并不能提高冻胚移植的活产率。
主要发现
- 富含透明质酸组与标准液组的活产率分别为25.5%与25.8%(相对风险0.99;95%置信区间0.74-1.31)。
- Logistic回归显示转移液类型与活产无关联。
- 两组其他临床结局也相似。
- 富含透明质酸组8例、对照组5例因胚胎解冻后未存活而未行冻胚移植;富含透明质酸组1例因发热取消移植,1例退出并接受常规转移液。
关键数值与推荐
- 富含透明质酸组使用EmbryoGlue(Vitrolife,哥德堡,瑞典),透明质酸浓度为0.5 mg/mL。
- 对照组使用补充的G-2(Vitrolife)转移液,透明质酸浓度为0.125 mg/mL。
- 主要结局为活产率。
临床怎么用
- 对于行冻胚移植的不孕女性,不应期望通过使用富含透明质酸的转移液来提高活产率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the effects of hyaluronic acid (HA)-enriched transfer medium versus standard medium on live birth rate after frozen embryo transfer (FET). DESIGN: Randomized, double-blind, controlled trial. SETTING: Two tertiary fertility centers. PATIENT(S): Infertile women aged <43 years at the time of in vitro fertilization undergoing FET. INTERVENTION(S): The women were randomly assigned to 2 groups in a 1:1 ratio. The HA group used EmbryoGlue (Vitrolife, Gothenburg, Sweden) with an HA concentration of 0.5 mg/mL, while the control group used supplemented G-2 (Vitrolife) medium with an HA concentration of 0.125 mg/mL. MAIN OUTCOME MEASURE(S): Live birth rate. RESULT(S): Five hundred fifty women were recruited from April 2016 to April 2018 and included in the intention-to-treat analysis. Eight women in the HA group and 5 women in the control group did not undergo FET because the embryos did not survive on thawing. One woman in the HA group cancelled FET because of fever. One woman in the HA group withdrew and received conventional medium. The 2 groups were similar in demographic characteristics. The live birth rates in the HA group and the control group were comparable (25.5% vs. 25.8%; relative risk 0.99; 95% confidence interval 0.74-1.31). The other clinical outcomes were also similar between the 2 groups. Logistic regression showed that the type of transfer medium was not associated with live birth. CONCLUSION(S): The use of HA-enriched transfer medium does not improve the live birth rate of FET compared with standard medium. TRIAL REGISTRATION NUMBER: NCT02725827 (ClinicalTrials.gov).
引用
- Yung SSF, Lai SF, Lam MT, et al. Hyaluronic acid-enriched transfer medium for frozen embryo transfer: a randomized, double-blind, controlled trial. Fertil Steril. 2021. PMID: 33845988. doi:10.1016/j.fertnstert.2021.02.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。